Samsung reported to be in in talks to buy Biogen for $42 billion...
Who would have tought there would be multi-billion dollar takeover shenanigans during a short, typically quiet holiday week.
The latest tale doing the rounds is about Samsung holding talks about takeover of Biogen, the US-listed biotechnology company that is developing a drug for Alhzeimer's...
Register
Register for free to see rest of this article and all public articles from Betaville
Login / RegisterDate: Thursday, 30 December 2021, 12:16 pm